A vial labeled 5 mg at 99% purity does not necessarily contain 4.95 mg of peptide. Purity and content are separate specifications measured by separate methods: purity describes the target's share of chromatographically detected material, while net peptide content describes what fraction of the vial's actual mass is peptide. The gap between them is water, salt, and counterion, and it can be substantial. This guide covers why the two numbers differ, how large the difference typically is, and how it shows up as batch variability.
Two specifications, two questions
Chromatographic purity answers a compositional question: among the species this HPLC method detected, what share was the target. It is a ratio derived from UV peak areas, typically at 214 nm where the peptide bond absorbs. Net peptide content answers a gravimetric question: of the total mass in this container, what fraction is peptide. These are independent quantities, and neither constrains the other. A batch can be highly pure and low in content, meaning almost everything peptidic present is the right peptide but a large share of the vial's mass is not peptide at all. The reverse is also possible. The distinction matters the moment a protocol equates labeled mass with compound mass, because that assumption depends on content, not purity, and the certificate usually reports only purity. Understanding what a report does and does not establish is the same discipline covered in the guide to verifying a vendor's testing claims.
Where the missing mass goes
Three components account for most of the difference. Counterions are the largest and most systematic. Peptides are purified by reverse-phase HPLC using trifluoroacetic acid, and basic residues retain TFA as a counterion through lyophilization. The load scales with the number of basic residues, so arginine- and lysine-rich sequences carry proportionally more, and for such sequences the counterion contribution to total mass is far from trivial. Water is the second component. Lyophilized peptides are hygroscopic, absorbing atmospheric moisture during handling and on each container opening, and residual water also remains from an incomplete drying cycle. Residual salts and solvents from synthesis and purification make up the third. None of these register meaningfully in a chromatographic purity calculation, because they do not absorb appreciably at the detection wavelength and therefore fall outside the ratio rather than counting against it. The purity figure is not wrong; it is answering a different question than the one about vial contents.
How the numbers are established
Net peptide content requires methods that measure peptide directly rather than by chromatographic share. Amino acid analysis is the reference approach: the sample is hydrolyzed into constituent amino acids, which are quantified against calibrated standards, yielding peptide mass independent of what else is present. Quantitative nitrogen determination provides a related measure based on nitrogen content. Water content is measured separately by Karl Fischer titration, and counterion load by dedicated counterion analysis, usually ion chromatography. UV quantitation against extinction coefficients can estimate concentration in solution for sequences containing aromatic residues, though it depends on the sequence having them. The practical implication is that a research-grade certificate reporting HPLC purity and mass spectrometry identity contains no content information at all, and content data has to be requested specifically. Many suppliers do not run these assays routinely, so the honest answer is often that the data does not exist for a given lot.
Reading a product page with this in mind
Product listings state a labeled mass, and the meaning of that number varies. It may refer to gross vial fill, total lyophilized mass including counterion and water, or to net peptide content, and the two can differ noticeably for a counterion-heavy sequence. Listings rarely specify which convention is in use, so it is worth asking directly rather than assuming. The purity percentage alongside it is a separate specification and does not resolve the ambiguity. Where a listing or certificate reports a salt form, such as an acetate or trifluoroacetate designation, that is a signal that counterion is part of the stated mass. The workable position is to regard labeled mass as approximate for quantitative purposes unless content data accompanies it, and to determine concentration empirically after solubilization when accuracy matters. That approach removes dependence on the labeling convention entirely.
Batch variability
Content varies between lots more than purity does, which is what makes it a practical concern rather than a theoretical one. Purification conditions shift slightly between runs, changing counterion load. Lyophilization cycles vary in completeness, changing residual moisture, and shelf position within a dryer can produce differences within a single run. Handling and ambient humidity during fill affect water uptake. The result is that two lots meeting the same purity specification can differ in actual peptide content, so a protocol calibrated on one lot may be systematically off on the next while every document still reads as compliant. This is a frequent and under-recognized source of what looks like biological variability between experiments. The mitigations are straightforward: use a single lot across an experimental series where possible, record lot numbers against datasets so a shift can be localized, and determine concentration in solution rather than from vial mass when a lot changes mid-study. Where sequences are counterion-heavy or storage has been long, those steps matter more.
When it matters and when it does not
The distinction is decisive for quantitative work where concentration must be accurate: concentration-response characterization, EC50 determination, reference standard preparation, and any comparison across batches or laboratories. It matters much less for qualitative or exploratory work, where a modest concentration offset does not change the conclusion, and it is irrelevant when concentration is determined empirically after solubilization rather than calculated from vial mass. The general rule is that content matters whenever labeled mass enters a calculation. Where it does, the appropriate action is to request content data or measure concentration directly, not to negotiate for a higher purity specification, since purity does not address the question. Keeping purity and content distinct in mind is what stops a well-documented batch from producing quietly wrong numbers.
FAQ
Does 99% purity mean 99% of the vial mass is peptide?
No. Purity is the target's share of chromatographically detected material. Water, salts, and counterions fall outside that measurement and can account for a meaningful portion of total vial mass.
What is the largest contributor to the gap?
Counterion load, typically trifluoroacetate from HPLC purification, scaling with the number of basic residues in the sequence. Residual water is the next largest.
How is net peptide content measured?
Amino acid analysis is the reference method, with quantitative nitrogen determination as an alternative. Water content and counterion load are measured separately by Karl Fischer titration and ion chromatography.
Why do two lots at the same purity behave differently?
Content varies with purification and lyophilization conditions more than purity does. Two compliant lots can differ in actual peptide mass, producing a concentration offset that reads as experimental variability.
How can this be avoided without content data?
Determine concentration in solution after solubilization rather than calculating from labeled vial mass. That removes dependence on both the content figure and the labeling convention.
Research Use Only: All compounds sold by Ever Vital are intended exclusively for laboratory research. Not for human use. These products are not drugs, supplements, or food. Statements have not been evaluated by the FDA. Must be 21+ to purchase.
Join the list.
Restock alerts, subscriber discounts, and first access to new compound drops.
